Kathmere Capital Management’s John Hancock Multifactor Large Cap ETF JHML Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-7,213
Closed -$469K 391
2024
Q2
$469K Hold
7,213
0.05% 183
2024
Q1
$467K Hold
7,213
0.05% 177
2023
Q4
$424K Hold
7,213
0.06% 161
2023
Q3
$382K Hold
7,213
0.06% 155
2023
Q2
$396K Hold
7,213
0.06% 133
2023
Q1
$374K Hold
7,213
0.06% 134
2022
Q4
$355K Hold
7,213
0.06% 126
2022
Q3
$328K Hold
7,213
0.07% 116
2022
Q2
$344K Hold
7,213
0.06% 104
2022
Q1
$409K Hold
7,213
0.07% 96
2021
Q4
$429K Hold
7,213
0.07% 82
2021
Q3
$392K Hold
7,213
0.07% 84
2021
Q2
$393K Hold
7,213
0.08% 89
2021
Q1
$367K Hold
7,213
0.07% 89
2020
Q4
$342K Hold
7,213
0.07% 82
2020
Q3
$301K Hold
7,213
0.07% 79
2020
Q2
$277K Hold
7,213
0.08% 89
2020
Q1
$231K Sell
7,213
-460
-6% -$17.8K 0.08% 71
2019
Q4
$316K Buy
+7,673
New +$305K 0.11% 75

Other funds holding JHML

Kathmere Capital Management's JHML Position: Q3 2024 in Review

Kathmere Capital Management sold out of John Hancock Multifactor Large Cap ETF (JHML) in Q3 2024, closing a stake of 7,213 shares — an estimated $469K sold.

Kathmere Capital Management first reported a position in JHML in Q4 2019 and held it in 19 quarters. The position peaked at $469K in Q2 2024. 100 funds tracked by Wall St. Rank hold JHML as of Q3 2024.

  • Kathmere Capital Management reported no remaining John Hancock Multifactor Large Cap ETF position as of Q3 2024 after selling out during the quarter.
  • Kathmere Capital Management sold 7,213 John Hancock Multifactor Large Cap ETF shares in Q3 2024, an estimated $469K.
  • Kathmere Capital Management first reported a position in John Hancock Multifactor Large Cap ETF in Q4 2019 and held it in 19 quarters.
  • Kathmere Capital Management's John Hancock Multifactor Large Cap ETF position peaked at $469K in Q2 2024.
  • 100 funds tracked by Wall St. Rank held John Hancock Multifactor Large Cap ETF as of Q3 2024.

Based on Kathmere Capital Management's 13F filing for Q3 2024, filed 15 Oct 2024.